Thomas John Dietz - 02 Oct 2024 Form 4 Insider Report for LEAP THERAPEUTICS, INC. (LPTX)

Role: Director
Signature: /s/ Douglas E. Onsi as attorney-in-fact for Thomas Dietz
Issuer symbol: LPTX
Transactions as of: 02 Oct 2024
Transactions value $: $0
Form type: 4
Filing time: 04 Oct 2024, 17:24:00 UTC
Previous filing: 31 Jan 2024
Next filing: 13 Nov 2025
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LPTX	Stock Option (Right to Buy)	Award	$0	+30,000		$0.000000	30,000	02 Oct 2024	Common Stock	30,000	$2.45	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of December 31, 2024, March 31, 2025, June 30, 2025, and September 30, 2025 for so long as the reporting person continues to be a director, consultant or service provider of the Company.

Content

The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of December 31, 2024, March 31, 2025, June 30, 2025, and September 30, 2025 for so long as the reporting person continues to be a director, consultant or service provider of the Company.